Ilari Lehtinen
Tampere, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Physicians' Tendency to Choose Palliative Care for an Advanced Dementia Patient Increases Concomitantly With Clinical Experience.
Journal: Journal of palliative care
Published: June 08, 2026
Adjuvant Docetaxel Versus Surveillance in Intermediate- or High-risk Prostate Cancer After Radical Curative Radiotherapy: Final Survival Results from the SPCG-13 Trial.
Journal: European urology oncology
Published: February 17, 2025
Safer and More Convenient Modern Curative Radiotherapy for Patients With Early Prostate Cancer.
Journal: Anticancer research
Published: November 13, 2023
2-weekly versus 3-weekly docetaxel for metastatic castration-resistant prostate cancer: complete quality of life results from the randomised, phase-III PROSTY trial.
Journal: Acta oncologica (Stockholm, Sweden)
Published: July 18, 2022
Health-related Quality of Life of Patients Treated With Different Fractionation Schedules for Early Prostate Cancer Compared to the Age-standardized General Male Population.
Journal: Clinical genitourinary cancer
Published: March 29, 2022
ANO7 rs77559646 Is Associated With First-line Docetaxel Treatment Response in Metastatic Castration-resistant Prostate Cancer.
Journal: Anticancer research
Published: August 29, 2019
Weekly paclitaxel--an effective treatment for advanced breast cancer.
Journal: Anticancer research
Published: June 11, 2013
Biweekly docetaxel is better tolerated than conventional three-weekly dosing for advanced hormone-refractory prostate cancer.
Journal: Anticancer research
Published: March 09, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026